Clinical features of spinal muscular atrophy (SMA) type 2

被引：0

作者：

Cances, C. ^{[1
]}

Richelme, C. ^{[2
]}

Barnerias, C. ^{[3
]}

Espil, C. ^{[4
]}

机构：

[1] Toulouse Univ Hosp, Neuropaediat Dept, AOC Atlantique Occitante Caraibe Reference Ctr Ne, Toulouse, France

[2] Hop Pediat Nice CHU Lenval, CMR Neuromusculaire PACARARE, Nice, France

[3] CMR Neuromusculaire NEIDF, AP HP, Paris, France

[4] CHU Bordeaux, Hop Enfants, CMR Neuromusculaire AOC, Bordeaux, France

来源：

ARCHIVES DE PEDIATRIE | 2020年 / 27卷 / 07期

关键词：

Spinal muscular atrophy type 2; Diagnosis semiology; Clinical evolution; PROSPECTIVE COHORT; MUSCLE STRENGTH; MOTOR FUNCTION; NUSINERSEN; CHILDREN; SURVIVAL; ADULTS;

D O I：

暂无

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Infantile spinal muscular atrophy (SMA) type 2 is sometimes called intermediate SMA to indicate the disease severity. Generally, psychomotor development is normal until the age of 6 to 8 months, with the acquisition of a stable sitting position. The early signs are muscle weakness, mostly affecting the lower limbs, generalized hypotonia and areflexia. The consequences of motor neuron degeneration are functional and orthopaedic, respiratory, nutritional, socio-professional, and psychological. The implementation of standardized care (i.e., standard of care recommendations) has improved the quality of life and survival outcome of patients. The emergence of innovative therapies, some of which are now available, should further improve the clinical evolution of this disease. (C) 2020 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.

引用

页码：18 / 22

页数：5

共 43 条

[1] Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study [J].

Audic, Frederique ;

de la Banda, Marta Gomez Garcia ;

Bernoux, Delphine ;

Ramirez-Garcia, Paola ;

Durigneux, Julien ;

Barnerias, Christine ;

Isapof, Arnaud ;

Cuisset, Jean-Marie ;

Cances, Claude ;

Richelme, Christian ;

Vuillerot, Carole ;

Laugel, Vincent ;

Ropars, Juliette ;

Altuzarra, Cecilia ;

Espil-Taris, Caroline ;

Walther-Louvier, Ulrike ;

Sabouraud, Pascal ;

Chouchane, Mondher ;

Vanhulle, Catherine ;

Trommsdorff, Valerie ;

Perville, Anne ;

Testard, Herve ;

Lagrue, Emmanuelle ;

Sarret, Catherine ;

Avice, Anne-Laude ;

Beze-Beyrie, Pierre ;

Pauly, Vanessa ;

Quijano-Roy, Susana ;

Chabrol, Brigitte ;

Desguerre, Isabelle .

ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)

[2]

Barois A, 1993, SOINS, V578, P18

[3]

Belaid A., 2016, AMYOTROPHIES SPINALE

[4] MOTOR MILESTONE ASSESSMENT OF INFANTS WITH SPINAL MUSCULAR ATROPHY USING THE HAMMERSMITH INFANT NEUROLOGICAL EXAM-PART 2: EXPERIENCE FROM A NUSINERSEN CLINICAL STUDY [J].

Bishop, Kathie M. ;

Montes, Jacqueline ;

Finkel, Richard S. .

MUSCLE & NERVE, 2018, 57 (01) :142-146

[5] INFANTILE MUSCULAR ATROPHY [J].

BYERS, RK ;

BANKER, BQ .

ARCHIVES OF NEUROLOGY, 1961, 5 (02) :140-&

[6] Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study [J].

Chabanon, Aurelie ;

Seferian, Andreea Mihaela ;

Daron, Aurore ;

Pereon, Yann ;

Cances, Claude ;

Vuillerot, Carole ;

De Waele, Liesbeth ;

Cuisset, Jean-Marie ;

Laugel, Vincent ;

Schara, Ulrike ;

Gidaro, Teresa ;

Gilabert, Stephanie ;

Hogrel, Jean-Yves ;

Baudin, Pierre-Yves ;

Carlier, Pierre ;

Fournier, Emmanuel ;

Lowes, Linda Pax ;

Hellbach, Nicole ;

Seabrook, Timothy ;

Toledano, Elie ;

Annoussamy, Melanie ;

Servais, Laurent .

PLOS ONE, 2018, 13 (07)

[7] Prevalence and Risk Factors for Feeding and Swallowing Difficulties in Spinal Muscular Atrophy Types II and III [J].

Chen, Yen-Shan ;

Shih, Hsiang-Hung ;

Chen, Tai-Heng ;

Kuo, Chang-Hung ;

Jong, Yuh-Jyh .

JOURNAL OF PEDIATRICS, 2012, 160 (03) :447-U137

[8] Spinal muscular atrophy: Survival pattern and functional status [J].

Chung, BHY ;

Wong, VCN ;

Ip, P .

PEDIATRICS, 2004, 114 (05) :E548-E553

[9] An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials [J].

Darras, Basil T. ;

Farrar, Michelle A. ;

Mercuri, Eugenio ;

Finker, Richard S. ;

Foster, Richard ;

Hughes, Steven G. ;

Bhan, Ishir ;

Farwell, Wildon ;

Gheuens, Sarah .

CNS DRUGS, 2019, 33 (09) :919-932

[10] Nusinersen in later-onset spinalmuscular atrophy Long-term results from the phase 1/2 studies [J].

Darras, Basil T. ;

Chiriboga, Claudia A. ;

Iannaccone, Susan T. ;

Swoboda, Kathryn J. ;

Montes, Jacqueline ;

Mignon, Laurence ;

Xia, Shuting ;

Bennett, C. Frank ;

Bishop, Kathie M. ;

Shefner, Jeremy M. ;

Green, Allison M. ;

Sun, Peng ;

Bhan, Ishir ;

Gheuens, Sarah ;

Schneider, Eugene ;

Farwell, Wildon ;

De Vivo, Darryl C. ;

Castro, Diana ;

Cowie, Margaret ;

Gilbreath, Heather ;

Johnson, Shanda ;

Kauk, Melissa ;

Khan, Muna ;

McElroy, Ebra ;

Kneirbein, Erin Neil ;

Nelson, Leslie ;

Smith, Lauren ;

Trest, Stephanie ;

Aziz-Zaman, Sonya ;

Cappell, Joshua ;

Constantinescu, Andrei ;

Cruz, Rosangel ;

Dastgir, Jahannaz ;

Dunaway, Sally ;

Holuba, Nicole ;

Khandji, Alexander G. ;

Kramer, Samantha ;

Marra, Jonathan ;

Ortiz-Miller, Courtney ;

Popolizio, Molly ;

Salazar, Rachel ;

Sanabria, Luz ;

Sproule, Douglas M. ;

Weimer, Louis ;

Berde, Charles ;

Binalsheikh, Ibrahim ;

Graham, Robert ;

Kang, Peter ;

Koka, Anjali ;

Landrigan-, Mary .

NEUROLOGY, 2019, 92 (21) :E2492-E2506

← 1 2 3 4 5 →